Optimization in screening and diagnosis of Prostate Cancer (PCa): Use of Prostate Health Index (PHI) and mMRI in biopsy-naive patients

Authors :: J.L. Gutiérrez Baños
E. Alonso Mediavilla
N. García Formoso
S. Zubillaga Guerrero
E. Herrero Blanco
G. Velilla Diez
F. Campos Juanatey
P. Lastra Garcia-Barón
E. Fernández Guzmán
A. Azueta Etxebarria
P. Calleja Hermosa
R. Ballestero Diego
M. Domínguez Esteban
R. Varea Malo
C. Redondo Figuero
E. Ramos Barseló
Source :: European Urology Open Science, Vol 19, Iss, Pp e163-e164 (2020)
Publication Year :: 2020
Publisher :: Elsevier, 2020.

Subjects :: Oncology
medicine.medical_specialty
medicine.diagnostic_test
business.industry
Urology
medicine.disease
lcsh:Diseases of the genitourinary system. Urology
lcsh:RC870-923
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
lcsh:RC254-282
Therapy naive
Prostate cancer
Health index
medicine.anatomical_structure
Prostate
Internal medicine
Biopsy
medicine
business

Tools